What are the recommended dosages for anesthetic agents, muscle relaxants, and anticholinergic premedications for Electroconvulsive Therapy (ECT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosages for ECT Medications

Primary Anesthetic Agent

Methohexital is the preferred anesthetic agent at a dose of 1.0 mg/kg IV 1, 2. This provides optimal anesthesia induction with adequate seizure duration for therapeutic efficacy 1, 2.

Alternative Anesthetic Agents

If methohexital is contraindicated, acceptable alternatives include 1:

  • Etomidate: Produces longer seizure durations than methohexital, though specific dosing ranges from 0.15-0.3 mg/kg IV 3
  • Propofol: 0.75-1.0 mg/kg IV, though this agent produces dose-dependent decreases in seizure duration and may require more treatments, particularly with right unilateral electrode placement 4, 3
  • Thiopental sodium: Acceptable alternative per guidelines 1
  • Ketamine: Acceptable alternative per guidelines 1

Important caveat: Propofol at 1.5 mg/kg significantly shortens seizure duration (motor: 20±6 s, EEG: 33±12 s) compared to lower doses, and should be avoided at higher dosing 3. Etomidate demonstrates no dose-dependent reduction in seizure duration across the 0.15-0.3 mg/kg range 3.

Muscle Relaxant

Succinylcholine at 0.9 mg/kg IV is the standard muscle relaxant 1, 2. This dose provides adequate muscle relaxation during ECT, though considerable individual variability exists 2.

Alternative Muscle Relaxants

If succinylcholine is contraindicated 1:

  • Atracurium: Acceptable alternative, though specific ECT dosing not provided in guidelines 1
  • Mivacurium: Acceptable alternative 1
  • Rocuronium: 0.3 mg/kg IV followed by sugammadex 1.5 mg/kg IV for reversal produces comparable seizure durations to succinylcholine 5

The rocuronium-sugammadex combination is a viable alternative when succinylcholine is contraindicated, producing similar EEG seizure durations (55.09±36.11 s vs 47.00±26.33 s) and clinical outcomes 5.

Anticholinergic Premedication

Atropine or glycopyrrolate must be administered immediately before ECT 1, 6. Specific dosing is not provided in guidelines, though standard practice uses glycopyrrolate 0.2 mg IV 3, 7.

Mandatory Administration Scenarios

Anticholinergic premedication is required in these situations 6:

  • Before seizure threshold determination by dose titration method
  • Before the first treatment with right unilateral electrode placement
  • To prevent bradycardia, arrhythmia, or cardiac asystole

Critical pitfall: Withholding anticholinergic medication during these scenarios leaves patients vulnerable to vagally-induced cardiac complications including asystole 6.

Ventilation Protocol

Patients must be ventilated with 100% oxygen before administration of the electrical stimulus 1, 6. This is a mandatory component of the ECT procedure 1.

Summary Dosing Table

Medication Class First-Line Agent Dose Alternatives
Anesthetic Methohexital 1.0 mg/kg IV Etomidate (0.15-0.3 mg/kg), Propofol (0.75-1.0 mg/kg), Thiopental, Ketamine
Muscle Relaxant Succinylcholine 0.9 mg/kg IV Rocuronium (0.3 mg/kg) + Sugammadex (1.5 mg/kg), Atracurium, Mivacurium
Anticholinergic Atropine or Glycopyrrolate 0.2 mg IV (glycopyrrolate) Either agent acceptable
Ventilation 100% Oxygen Before stimulus Mandatory

1, 6, 2, 3, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.